Evidence map›Paper›PMID 29773655›Full record

ArticleThe Journal of biological chemistry2018

FOXP3 interacts with hnRNPF to modulate pre-mRNA alternative splicing.

Jianguang Du, Qun Wang, Steven F Ziegler, Baohua Zhou

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Defects in CD8bioRxiv : the preprint server for biology · 2026
    Article
  4. Review
  5. Article
  6. Promoter Specificity and Transcription Levels ModulateInternational journal of molecular sciences · 2025
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. The emerging role of transcription factor FOXP3 in thyroid cancer.Reviews in endocrine & metabolic disorders · 2022
    Review
  12. Article
  13. Aberrant Bcl-x splicing in cancer: from molecular mechanism to therapeutic modulation.Journal of experimental & clinical cancer research : CR · 2021
    Review
  14. CD4Journal of the American Heart Association · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Jianguang DuFrom the Wells Center for Pediatric Research and Department of Pediatrics and.
Qun WangFrom the Wells Center for Pediatric Research and Department of Pediatrics and.
Steven F ZieglerBenaroya Research Institute at Virginia Mason, Seattle, Washington 98101.
Baohua ZhouFrom the Wells Center for Pediatric Research and Department of Pediatrics and zhoub@iu.edu.
Indiana University – Purdue University Indianapolis · USBenaroya Research InstituteIndiana University School of Medicine

Funding

TSLP in Th2 Immunity and Allergic Airway InflammationR01AI085046 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI ZHOU, BAOHUA · 2010 to 2019
$3.8M
FOXP3 Regulates RNA Alternative Splicing in TregsR21AI110773 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI ZHOU, BAOHUA · 2015 to 2016
$429k
NIAID NIH HHS R01 AI085046NIAID NIH HHS R21 AI110773
6 · The paper itself

Abstract

FOXP3 promotes the development and function of regulatory T cells mainly through regulating the transcription of target genes. RNA alternative splicing has been implicated in a wide range of physiological and pathophysiological processes. We report here that FOXP3 associates with heterogeneous nuclear ribonucleoprotein (hnRNP) F through the exon 2-encoded region of FOXP3 and the second quasi-RNA recognition motif (qRRM) of hnRNPF. FOXP3 represses the ability of hnRNPF to bind to its target pre-mRNA and thus modulates RNA alternative splicing. Furthermore, overexpression of mouse hnRNPF in

Indexed as

Alternative SplicingAnimalsbcl-X ProteinForkhead Transcription FactorsGene Expression RegulationHEK293 CellsHeterogeneous-Nuclear Ribonucleoprotein Group F-HHumansMiceProtein BindingRNA-Binding ProteinsRNA, MessengerRNA PrecursorsT-Lymphocytes, RegulatoryTrans-Activation Responsive RNA-Binding Proteinbcl-X ProteinForkhead Transcription FactorsFOXP3 protein, humanHeterogeneous-Nuclear Ribonucleoprotein Group F-HRNA-Binding ProteinsRNA, MessengerRNA PrecursorsTrans-Activation Responsive RNA-Binding Proteinalternative splicingforkhead box P3 (FOXP3)heterogeneous nuclear ribonucleoprotein (hnRNP)immunologyimmunosuppressionRNA-protein interactionRNA splicingTreg

Identifiers

PMID29773655
PMCPMC6028976
OpenAlexW2803340036

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.